Sprout Pharmaceuticals, Inc. Company
.jpg)
Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction. In 2015, the FDA approved Sprout Pharmaceuticals’s Addyi, also known under the generic name flibanserin, for use by pre-menopausal women with hypoactive sexual desire disorder (HSDD).
Industry:
Sexual Health
Headquarters:
Raleigh, North Carolina, United States
Founded Date:
01-01-2011
Employees Number:
51-100
Funding Status:
M&A
Total Funding:
$129,372,990
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-05-05
Last Funding Type:
Convertible Note
Register and Claim Ownership